Cognition adds 13% to plans to start Alzheimer’s trial for lead candidate Share this:FacebookX Related Post navigation Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants Pre-Funded by Investing.com Stocks rise after strong sell-off